1st Oct 2015 15:20
LONDON (Alliance News) - Premaitha Health PLC Thursday said Illumina Inc, which has filed a lawsuit against the company claiming patent infringement, has added a third patent to its claim against the company.
Illumina filed a case against Premaitha Health in March over two patents licensed to Illumina by Sequenom Inc covering the use of cell-free fetal DNA for non-invasive prental testing. Premaitha has filed a defence and counter-claim in response.
On Thursday, Premaitha said Illumina has added a third patent to the two previously asserted in the suit in the UK High Court of Justice. The newly added patent filing is EP2183693, but no other detaisl were released.
"The Directors believe that the IONA test does not infringe these patents as claimed by Illumina and the alleged infringement is unfounded," it reasserted on Thursday.
Premaitha shares were up 1.1% to 13.28 pence per share on Thursday.
By Joshua Warner; [email protected]; @JoshAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health